New UK programme with the RBM Partnership to End Malaria will boost global efforts to end malaria epidemic, stimulate growth and protect women and girls.
- Global progress has stalled in recent years with the climate crisis increasing threats posed by malaria.
- Fresh support will galvanise global leaders in the fight against malaria, combat resistance to drugs and insecticides, and assist four countries in Africa to tackle the disease.
- Follows the rollout of two malaria vaccines, developed with British scientific expertise.
Efforts to tackle malaria have today received a boost from the UK government, with a new £5 million programme with the RBM Partnership to End Malaria (RBM) set to renew the push to end the epidemic by 2030.
The announcement follows the launch of the World Health Organization (WHO)'s World Malaria Report 2024, which shows that malaria remains a serious global health challenge with a rise in cases in 2023.
The UK's new partnership will support RBM as it galvanises global leaders in the fight against malaria. This includes tackling resistance to malaria treatments and supporting efforts to control malaria in four countries: Cameroon, Nigeria, Tanzania and Uganda.
Tackling malaria will also help unlock growth in the Global South. Analysis shows reducing malaria cases by 90% by 2030 could boost GDP by over $142 billion in malaria-endemic countries.
Minister for Development Anneliese Dodds said:
Thanks to the expertise of British scientists and the efforts of partners across the world, we have shown that the malaria epidemic can be ended.
But in the Global South too many are still losing their lives and livelihoods to the disease, with pregnant women and children especially vulnerable.
The UK is pleased to be partnering with the RBM Partnership to End Malaria, contributing £5 million to reenergise global efforts to tackle the epidemic. With the right tools, treatments and leadership, we can get back on track to end malaria, save lives and unlock billions in economic growth.
Progress against malaria has stalled in recent years and the world is off track against the Sustainable Development Goal (SDG) target to end the epidemic of malaria by 2030.
The climate crisis is hindering efforts to end malaria as extreme weather events, such as flooding, increase the risk of outbreaks and warming temperatures change patterns of transmission.
The UK's partnership with RBM solidifies the UK as a key partner in global efforts to end malaria. The UK is also a leading supporter to Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis and Malaria, and supports research into new tools to prevent and treat malaria.
British scientists helped develop two malaria vaccines which have the potential to save millions of lives. With UK support, Gavi, the Vaccine Alliance are helping to roll out the new vaccines in up to 25 countries by 2025, including in Nigeria last week (2 December). This week, Minister Dodds is in Malawi, one of three countries where the RTS,S vaccine was shown to reduce child mortality by 13%. A third vaccine, which targets the disease at a later stage of infection, is being tested by British scientists at the University of Oxford.
